OptimizeRx (OPRX) Depreciation & Amortization (IS) (2022 - 2025)
OptimizeRx's Depreciation & Amortization (IS) history spans 4 years, with the latest figure at $1.1 million for Q3 2025.
- For Q3 2025, Depreciation & Amortization (IS) fell 1.28% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $4.3 million, up 2.38%, while the annual FY2024 figure was $4.3 million, 80.22% up from the prior year.
- Depreciation & Amortization (IS) for Q3 2025 was $1.1 million at OptimizeRx, up from $1.1 million in the prior quarter.
- Across five years, Depreciation & Amortization (IS) topped out at $1.1 million in Q3 2024 and bottomed at $456544.0 in Q4 2022.
- The 4-year median for Depreciation & Amortization (IS) is $1.0 million (2023), against an average of $800119.3.
- The largest annual shift saw Depreciation & Amortization (IS) fell 19.61% in 2023 before it surged 134.98% in 2024.
- A 4-year view of Depreciation & Amortization (IS) shows it stood at $456544.0 in 2022, then soared by 120.57% to $1.0 million in 2023, then rose by 8.64% to $1.1 million in 2024, then decreased by 1.19% to $1.1 million in 2025.
- Per Business Quant, the three most recent readings for OPRX's Depreciation & Amortization (IS) are $1.1 million (Q3 2025), $1.1 million (Q2 2025), and $1.1 million (Q1 2025).